Profile data is unavailable for this security.
About the company
Advanced Medical Solutions Group plc is an independent developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. Its surgical products, including tissue adhesives, suture, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec and Seal-G. It also supplies wound care dressings, such as silver alginates, alginates and foams through its ActivHeal brand, and under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit comprises a multi-product portfolio of advanced woundcare dressings and a portfolio of specialist medical bulk materials and multi-layer woundcare and bio-diagnostics products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel.
- Revenue in GBP (TTM)220.30m
- Net income in GBP9.12m
- Incorporated1993
- Employees1.50k
- LocationAdvanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
- Phone+44 160 686 3500
- Fax+44 160 686 3600
- Websitehttps://www.admedsol.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellaVision AB | 62.33m | 12.57m | 297.34m | 236.00 | 23.65 | 4.08 | 18.82 | 4.77 | 6.42 | 6.42 | 31.82 | 37.21 | 0.7201 | 2.02 | 6.80 | -- | 14.52 | 14.71 | 16.22 | 16.96 | 68.50 | 68.38 | 20.17 | 19.85 | 2.97 | 25.88 | 0.0281 | 41.97 | 4.94 | 9.99 | 8.78 | 11.34 | 20.76 | 29.67 |
| IVF Hartmann Holding AG | 153.78m | 18.34m | 319.44m | 309.00 | 17.42 | 2.28 | 13.68 | 2.08 | 7.92 | 7.92 | 66.39 | 60.57 | 0.8964 | 3.28 | 7.88 | 526,221.10 | 10.69 | 7.90 | 12.91 | 9.68 | 55.71 | 54.06 | 11.93 | 9.13 | 3.79 | -- | 0.0042 | 48.54 | 7.33 | 2.85 | 34.02 | 10.78 | -28.94 | 19.92 |
| Medistim ASA | 52.12m | 11.10m | 325.94m | 154.00 | 29.27 | 9.95 | 24.74 | 6.25 | 7.79 | 7.79 | 36.56 | 22.91 | 1.25 | 0.7679 | 9.67 | 4,341,637.00 | 26.72 | 21.98 | 33.09 | 27.19 | 81.21 | 78.66 | 21.30 | 20.32 | 2.03 | -- | 0.0484 | 85.04 | 6.88 | 9.12 | 0.0087 | 8.11 | 12.53 | 16.89 |
| COLTENE Holding AG | 232.16m | 13.81m | 330.24m | 1.18k | 23.92 | 3.79 | 16.26 | 1.42 | 2.40 | 2.40 | 40.22 | 15.13 | 1.31 | 1.34 | 6.40 | 204,684.50 | 7.80 | 10.59 | 14.26 | 18.43 | 66.11 | 62.19 | 5.95 | 7.64 | 0.7043 | 7.62 | 0.3606 | 85.66 | 3.06 | -1.79 | 71.31 | 0.4306 | -15.45 | 10.76 |
| medmix AG | 451.47m | -5.59m | 376.08m | 2.67k | -- | 0.9096 | 8.01 | 0.833 | -0.1696 | -0.1696 | 11.60 | 10.39 | 0.4707 | 3.56 | 5.86 | 174,403.90 | -0.4927 | 1.27 | -0.6199 | 1.55 | 34.52 | 35.24 | -1.05 | 2.65 | 1.10 | 1.87 | 0.4268 | 140.79 | -0.5549 | 2.84 | -2,566.67 | -- | 6.02 | -- |
| Ion Beam Applications SA | 522.68m | 14.90m | 408.02m | 2.10k | 27.09 | 3.79 | 15.80 | 0.7806 | 0.5677 | 0.5677 | 20.17 | 4.06 | 0.9756 | 2.73 | 3.28 | 281,693.60 | 2.78 | 1.50 | 12.03 | 4.64 | 31.21 | 34.39 | 2.85 | 2.15 | 0.6209 | 7.41 | 0.3631 | 70.81 | 6.75 | 12.01 | 201.57 | 3.99 | 7.69 | 25.86 |
| Revenio Group Oyj | 96.10m | 15.24m | 434.76m | 247.00 | 28.44 | 4.31 | 22.76 | 4.52 | 0.654 | 0.654 | 4.12 | 4.31 | 0.7515 | 3.05 | 7.26 | 444,129.60 | 11.92 | 14.00 | 14.23 | 17.40 | 70.92 | 70.95 | 15.86 | 19.38 | 1.63 | 9.66 | 0.0969 | -- | 5.97 | 12.43 | -5.93 | 5.42 | 22.19 | -- |
| Lumibird SA | 189.18m | 9.40m | 442.85m | 1.07k | 47.12 | 2.53 | 16.61 | 2.34 | 0.4775 | 0.4775 | 9.61 | 8.90 | 0.5077 | 0.9593 | 4.42 | 202,198.50 | 2.52 | 2.51 | 3.11 | 3.17 | 63.89 | 61.89 | 4.97 | 4.90 | 1.64 | 3.16 | 0.4583 | 0.00 | 1.75 | 13.34 | -20.08 | -8.38 | 15.27 | -- |
| Advanced Medical Solutions Group plc | 220.30m | 9.12m | 471.01m | 1.50k | 51.45 | 1.84 | 15.50 | 2.14 | 0.0417 | 0.0417 | 1.01 | 1.17 | 0.5758 | 2.09 | 5.57 | 137,690.00 | 2.38 | 5.09 | 2.63 | 5.52 | 52.19 | 55.06 | 4.14 | 11.15 | 1.55 | 3.88 | 0.2428 | 33.47 | 40.66 | 11.64 | -55.35 | -17.81 | 8.36 | 10.90 |
| RaySearch Laboratories AB (publ) | 110.40m | 18.71m | 484.63m | 458.00 | 28.82 | 6.67 | 11.38 | 4.39 | 6.65 | 6.65 | 39.25 | 28.74 | 0.6584 | 6.25 | 2.93 | 2,935,074.00 | 11.16 | 5.26 | 16.21 | 7.77 | 92.42 | 91.01 | 16.94 | 9.70 | 1.66 | 64.92 | 0.2861 | 52.38 | 12.77 | 15.58 | 11.93 | -- | 0.2213 | -- |
| Xvivo Perfusion AB | 66.70m | 2.07m | 485.04m | 198.00 | 235.33 | 2.79 | 61.93 | 7.27 | 0.7968 | 0.7968 | 25.76 | 67.10 | 0.34 | 0.8939 | 6.13 | 4,101,844.00 | 1.05 | 3.28 | 1.12 | 3.52 | 73.81 | 73.86 | 3.10 | 10.87 | 3.68 | 1.83 | 0.0557 | 0.00 | -1.25 | 35.19 | -85.39 | -- | -- | -- |
| Gerresheimer AG | 1.97bn | 20.46m | 512.89m | 13.54k | 25.07 | 0.4176 | 2.10 | 0.2602 | 0.676 | 0.676 | 65.15 | 40.59 | 0.5455 | 3.73 | 7.85 | 185,328.90 | 0.6341 | 3.30 | 0.8716 | 4.68 | 26.89 | 30.04 | 1.16 | 5.84 | 0.5214 | 2.08 | 0.6022 | 41.29 | 2.28 | 7.90 | -5.52 | 6.32 | 17.58 | -49.35 |
| Synektik SA | 146.49m | 28.02m | 530.80m | 203.00 | 18.94 | 9.90 | 16.68 | 3.62 | 15.84 | 12.20 | 82.79 | 30.29 | 1.30 | 6.46 | 5.73 | -- | 24.78 | 20.11 | 45.33 | 32.67 | 36.50 | 31.40 | 19.13 | 13.60 | 1.22 | 111.98 | 0.1114 | -- | 9.16 | 40.29 | 51.58 | 70.02 | 28.82 | -- |
| Arjo AB (publ) | 903.45m | 27.43m | 564.80m | 6.94k | 22.07 | 0.9884 | 4.82 | 0.6252 | 1.23 | 1.23 | 40.39 | 27.38 | 0.704 | 4.92 | 6.22 | 1,584,702.00 | 2.14 | 3.26 | 2.91 | 4.80 | 42.59 | 43.42 | 3.04 | 4.78 | 0.8494 | 3.99 | 0.4179 | 48.74 | -2.59 | 3.92 | -32.93 | -8.68 | -- | 2.25 |
| GVS SpA | 370.07m | 20.03m | 662.92m | 4.23k | 30.24 | 1.75 | 11.12 | 1.79 | 0.1323 | 0.1323 | 2.35 | 2.28 | 0.475 | 2.02 | 7.01 | 99,768.77 | 2.57 | 6.01 | 3.33 | 8.53 | 56.11 | 57.98 | 5.41 | 11.16 | 0.7567 | 2.40 | 0.4234 | -- | 0.8959 | 13.51 | 144.52 | 0.1729 | 23.38 | -- |
| Paul Hartmann AG | 2.13bn | 71.40m | 676.01m | 10.09k | 9.41 | 0.6544 | 4.01 | 0.318 | 22.95 | 22.95 | 682.93 | 330.05 | 1.16 | 1.97 | 5.54 | 240,745.70 | 4.12 | 4.21 | 5.45 | 5.79 | 59.56 | 57.30 | 3.56 | 3.35 | 1.11 | 14.11 | 0.2465 | 37.95 | 2.32 | 1.95 | 281.58 | 13.23 | 10.08 | 2.71 |
Data as of Mar 02 2026. Currency figures normalised to Advanced Medical Solutions Group PLC's reporting currency: UK Pound GBX
38.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Octopus Investments Ltd.as of 15 Oct 2025 | 24.12m | 10.99% |
| Canaccord Genuity Wealth Ltd.as of 30 Apr 2025 | 14.40m | 6.56% |
| Raymond James Wealth Management Ltd. (Investment Management)as of 02 May 2025 | 9.02m | 4.11% |
| Rathbones Investment Management Ltd.as of 30 Apr 2025 | 7.17m | 3.27% |
| Invesco Asset Management Ltd.as of 30 Apr 2025 | 6.55m | 2.98% |
| AXA Investment Managers UK Ltd.as of 27 Mar 2025 | 5.59m | 2.55% |
| Briarwood Chase Management LLCas of 04 Apr 2025 | 4.78m | 2.18% |
| Brooks Macdonald Asset Management Ltd.as of 23 Apr 2025 | 4.25m | 1.93% |
| Chelverton Asset Management Ltd.as of 31 Mar 2025 | 3.94m | 1.79% |
| Royal London Asset Management Ltd.as of 07 Apr 2025 | 3.63m | 1.65% |
More ▼
Data from 31 Jul 2025 - 18 Feb 2026Source: FactSet Research Systems Inc.
